Case studies on the characterization & clinical development of agonistic antibody therapeutics targeting checkpoint receptors.
Read MoreYour search results
Showing 13–24 of 280 results
Accelerate the Development of Peptide Therapeutics for Obesity & Diabetes With MOA-Reflective Assays — Assays for Screening, Profiling, Potency, &…
Read MoreJennifer Lin-Jones, Ph.D., Associate Director of Assay Development R&D Department, Eurofins DiscoverX
Read MoreWatch this webinar to discover functional cell-based assays for characterizing novel therapeutics & biosimilars targeting cytokines in inflammation & oncology.
Watch NowStriatal-enriched protein tyrosine phosphatase (STEP) is a brain-specific enzyme that regulates the signaling molecules that control synaptic plasticity and neuronal…
Read MoreThe MAS-related Gq protein-coupled receptor X4 (MRGPRX4) is poorly investigated. MRGPRX4 has been proposed to be involved in pain transmission,…
Read MoreAgonistic Antibodies and the Role of Checkpoint Receptors in Immune Function
Read MoreWatch this webinar to discover qualified bioassays assessing therapeutic antibody mechanisms, case studies about agonistic effects in antibodies initially deemed…
Watch NowThe clinical success of an ever-increasing array of biologics has led to the development of a wide spectrum of immunomodulatory…
Read More